A life-course approach to immunisation
Programmes that support immunisation across the life course can improve population health and promote health system sustainability. International examples of best practice offer valuable lessons for implementing policies that support immunisation throughout life.
What we achieved
HPP was commissioned by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) to research and develop a report and policy framework to support policymakers considering how to implement a life-course approach to immunisation.
Through desk research and interviews with experts in six countries (Australia, Brazil, France, Japan, the United Kingdom and the United States), we identified five key components needed for effective life-course immunisation policy and assessed the progress of each country against them. The five components are:
- Comprehensive immunisation programme that supports vaccine availability
- Public demand for immunisation
- Engaged healthcare professionals
- Multidisciplinary and cross-sectoral coordination
- Robust data informing policies and programmes.
The report also includes 15 case studies and six country profiles to demonstrate examples of best practice and lessons which can be applied in other contexts.
The report and infographic were launched in September 2019 to coincide with the European Commission Global Vaccination Summit.
Key partners and stakeholders
The content of this report was developed in close consultation with the IFPMA Life-Course Immunization Working Group, which is formed of representatives from a number of IFPMA members.
Immunisation experts who were interviewed and provided feedback on this report:
- Ray Borrow, Public Health England
- Kelly Carulli, Audacious Inquiry
- Catherine Heffernan, Immunisations and Vaccination services NHS England
- James Daniel, US Department of Health and Human Service
- Jean-Louis Koeck, MesVaccins
- Lonnie Peterson, Washington State Department of Health
- Jonathan Raviotta, University of Pittsburgh
- Rosana Richtmann, Instituto de Infectologia Emilio Ribas
- Rekah Shah, Pharmacy London
- Shannon Stokley, Immunization Services Division, CDC
- Nicola Thorley, University Hospitals Birmingham NHS Foundation Hospitals Trust
- Richard Zimmerman, University of Pittsburgh
- Members of the PhRMA committee